1. Home
  2. ABR vs NVAX Comparison

ABR vs NVAX Comparison

Compare ABR & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arbor Realty Trust

ABR

Arbor Realty Trust

HOLD

Current Price

$5.93

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$9.23

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABR
NVAX
Founded
2003
1987
Country
United States
United States
Employees
653
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
ABR
NVAX
Price
$5.93
$9.23
Analyst Decision
Hold
Hold
Analyst Count
5
9
Target Price
$9.90
$11.33
AVG Volume (30 Days)
4.0M
4.6M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
15.42%
N/A
EPS Growth
N/A
309.76
EPS
N/A
N/A
Revenue
N/A
$1,123,479,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.29
N/A
Revenue Growth
N/A
64.69
52 Week Low
$5.69
$6.20
52 Week High
$12.58
$11.85

Technical Indicators

Market Signals
Indicator
ABR
NVAX
Relative Strength Index (RSI) 25.14 55.25
Support Level N/A $9.14
Resistance Level $8.15 $10.63
Average True Range (ATR) 0.33 0.61
MACD -0.25 0.18
Stochastic Oscillator 7.89 49.01

Price Performance

Historical Comparison
ABR
NVAX

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: